You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for ZIDOVUDINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ZIDOVUDINE

Average Pharmacy Cost for ZIDOVUDINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ZIDOVUDINE 300 MG TABLET 31722-0509-60 0.45435 EACH 2025-01-22
ZIDOVUDINE 300 MG TABLET 65862-0024-60 0.45435 EACH 2025-01-22
ZIDOVUDINE 300 MG TABLET 31722-0509-60 0.46145 EACH 2024-12-18
ZIDOVUDINE 300 MG TABLET 65862-0024-60 0.46145 EACH 2024-12-18
ZIDOVUDINE 300 MG TABLET 65862-0024-60 0.48097 EACH 2024-11-20
ZIDOVUDINE 300 MG TABLET 31722-0509-60 0.48097 EACH 2024-11-20
ZIDOVUDINE 300 MG TABLET 65862-0024-60 0.47566 EACH 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for ZIDOVUDINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
RETROVIR 50MG/5ML SYRUP ViiV HealthCare Company 49702-0212-48 240ML 47.51 0.19796 ML 2023-01-01 - 2026-08-14 Big4
RETROVIR 100MG CAP ViiV HealthCare Company 49702-0211-20 100 202.99 2.02990 EACH 2024-01-01 - 2026-08-14 Big4
RETROVIR IV INF 20ML VIAL ViiV HealthCare Company 49702-0213-26 5X20ML 143.75 2022-01-01 - 2026-08-14 FSS
RETROVIR 100MG CAP ViiV HealthCare Company 49702-0211-20 100 191.85 1.91850 EACH 2021-08-15 - 2026-08-14 Big4
RETROVIR 50MG/5ML SYRUP ViiV HealthCare Company 49702-0212-48 240ML 63.78 0.26575 ML 2023-01-01 - 2026-08-14 FSS
RETROVIR 100MG CAP ViiV HealthCare Company 49702-0211-20 100 265.79 2.65790 EACH 2024-01-01 - 2026-08-14 FSS
RETROVIR IV INF 20ML VIAL ViiV HealthCare Company 49702-0213-26 5X20ML 107.53 2023-01-01 - 2026-08-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Zidovudine

Introduction to Zidovudine

Zidovudine, also known by its brand name Retrovir, is a nucleoside reverse transcriptase inhibitor (NRTI) used primarily in the treatment and prevention of HIV infection. It is a crucial component of antiretroviral therapy (ART) and has been a cornerstone in HIV management since its introduction.

Market Size and Forecast

The global zidovudine market is anticipated to experience significant growth over the forecast period. Here are some key projections:

  • Market Size: The zidovudine market is expected to grow at a Compound Annual Growth Rate (CAGR) of 3 to 5% from 2023 to 2031, reaching an estimated valuation of several hundred million USD by 2031[2].
  • Segmentation: The market is segmented by type (oral and injectable) and application (HIV treatment and HIV prevention). The oral form is expected to dominate the market due to its ease of administration and higher patient compliance[2].

Drivers and Restraints

Drivers

  • Increasing Prevalence of HIV: The rising number of HIV cases globally is a significant driver for the zidovudine market. As more people are diagnosed and treated, the demand for antiretroviral drugs like zidovudine increases[2][3].
  • Advancements in Healthcare: Improvements in healthcare infrastructure, especially in developing countries, have enhanced access to antiretroviral therapies, boosting the market for zidovudine.
  • Government Initiatives: Various government programs and international organizations' efforts to combat HIV/AIDS have increased the availability and affordability of zidovudine[2].

Restraints

  • Side Effects and Resistance: Zidovudine can have significant side effects, and the development of drug resistance is a major concern. These factors can limit market growth[5].
  • Competition from Newer Drugs: The emergence of newer, more effective antiretroviral drugs can reduce the demand for zidovudine[3].

Regional Analysis

The global zidovudine market is geographically segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.

  • North America: This region is expected to be a significant market due to advanced healthcare systems and high awareness about HIV treatment[2].
  • Asia-Pacific: This region is anticipated to show rapid growth due to increasing healthcare expenditure and a large patient population[2].

Price Projections

The cost of zidovudine can vary based on the form and dosage.

  • Oral Tablets: The cost for zidovudine 300 mg oral tablets is around $42 for a supply of 60 tablets, depending on the pharmacy[5].
  • Oral Capsules: The cost for 100 capsules of 100 mg zidovudine oral capsules can range from $181.15[5].
  • Oral Syrup: The cost for 240 milliliters of 50 mg/5 mL zidovudine oral syrup is approximately $48.67[5].

Competitive Landscape

The zidovudine market includes several key players:

  • Pharma Waldhof GmbH (Aceto Corporation)
  • Beike Biology Pharmacy
  • Other major pharmaceutical companies involved in the HIV drugs market, such as ViiV Healthcare, Gilead Sciences, and GlaxoSmithKline, also play a significant role in the distribution and development of zidovudine[2][3].

Market Trends and Opportunities

Technological Advancements

  • Improvements in drug formulation and delivery systems can enhance the efficacy and patient compliance of zidovudine.
  • Generic Versions: The availability of generic versions of zidovudine can increase market penetration, especially in cost-sensitive regions[2].

Challenges

  • COVID-19 Impact: The COVID-19 pandemic has disrupted supply chains and affected healthcare services, which can impact the availability and affordability of zidovudine.
  • Economic Factors: Economic downturns can reduce healthcare spending, affecting the demand for zidovudine[3].

Consumer Behavior Analysis

Consumer behavior in the zidovudine market is influenced by several factors:

  • Awareness and Education: Increased awareness about HIV treatment and the importance of antiretroviral therapy drives demand for zidovudine.
  • Affordability: The availability of patient assistance programs and discounts can make zidovudine more accessible to a wider population[5].

ESG and Regulatory Analysis

Environmental, Social, and Governance (ESG) factors and regulatory environments play a crucial role in the zidovudine market:

  • Regulatory Approvals: Strict regulatory approvals ensure the safety and efficacy of zidovudine, which is essential for market growth.
  • Sustainability: Pharmaceutical companies are increasingly focusing on sustainable practices, which can impact the production and distribution of zidovudine[1].

Key Takeaways

  • The global zidovudine market is expected to grow at a CAGR of 3 to 5% from 2023 to 2031.
  • The oral form of zidovudine dominates the market due to its ease of administration.
  • Increasing prevalence of HIV, advancements in healthcare, and government initiatives are key drivers.
  • Side effects, drug resistance, and competition from newer drugs are significant restraints.
  • North America and Asia-Pacific are expected to be major regions for market growth.

FAQs

1. What is the expected CAGR of the zidovudine market from 2023 to 2031?

  • The zidovudine market is expected to grow at a CAGR of 3 to 5% from 2023 to 2031[2].

2. Which segment dominates the zidovudine market?

  • The oral segment dominates the zidovudine market due to its ease of administration and higher patient compliance[2].

3. What are the key drivers of the zidovudine market?

  • Key drivers include the increasing prevalence of HIV, advancements in healthcare, and government initiatives to combat HIV/AIDS[2][3].

4. What are the major restraints of the zidovudine market?

  • Major restraints include side effects, drug resistance, and competition from newer antiretroviral drugs[3][5].

5. Which regions are expected to dominate the zidovudine market?

  • North America and Asia-Pacific are expected to be the dominant regions for the zidovudine market[2].

Cited Sources

  1. Global Zidovudine Market Report 2024 Edition - Cognitivemarketresearch.com
  2. Global zidovudine market size and forecast - Marketresearchintellect.com
  3. HIV Drugs Market Size, Share | Growth Forecast [2024-2032] - Snsinsider.com
  4. Global Lamivudine and Zidovudine Market Research Report 2024 - Marketresearchreports.com
  5. Zidovudine Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.